| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Acute myeloid leukemia 7 genes, 12 drugs (DrugBank), 42 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [4] BRAF, FLT3, KIT, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] FLT3, KIT |
D10062 |
Cabozantinib |
[1] 34 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 2 | Adherens junction 3 genes, 4 drugs (DrugBank), 7 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] MET |
D10062 |
Cabozantinib |
[1] 34 |
| 3 | Adipocytokine signaling pathway 2 genes, 6 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 4 | Adrenergic signaling in cardiomyocytes 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] SCN5A |
D00354 |
Lamotrigine |
[3] 13, 34, 114 |
| 5 | African trypanosomiasis 4 genes, 3 drugs (DrugBank), 19 diseases shown |
[4] IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 6 | AGE-RAGE signaling pathway in diabetic complications 6 genes, 5 drugs (DrugBank), 26 diseases shown |
[5] CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 7 | Alanine, aspartate and glutamate metabolism 4 genes, 1 drug (DrugBank), 14 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 8 | Alcoholism 5 genes, 7 drugs (DrugBank), 8 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] MAP2K1 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] NTRK2 |
D10062 |
Cabozantinib |
[1] 34 |
| [1] SLC6A3 |
D01296 |
Methylphenidate |
[7] 6, 13, 34, 84, 113, 179, 206 |
| D04999 |
| 9 | Aldosterone synthesis and secretion 3 genes, 1 drug (DrugBank), 14 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 10 | Allograft rejection 2 genes, 3 drugs (DrugBank), 19 diseases shown |
[2] IL10, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 11 | Alzheimer disease 2 genes, 3 drugs (DrugBank), 19 diseases shown |
[2] IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 12 | Amoebiasis 4 genes, 3 drugs (DrugBank), 19 diseases shown |
[4] IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 13 | Amphetamine addiction 1 gene, 1 drug (DrugBank), 7 diseases shown |
[1] SLC6A3 |
D01296 |
Methylphenidate |
[7] 6, 13, 34, 84, 113, 179, 206 |
| D04999 |
| 14 | AMPK signaling pathway 2 genes, 5 drugs (DrugBank), 50 diseases shown |
[1] HMGCR |
D00359 |
Lovastatin |
[10] 6, 34, 46, 79, 156, 160, 195, 206, 263, 310 |
| D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 15 | Amyotrophic lateral sclerosis (ALS) 1 gene, 3 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 16 | Antifolate resistance 5 genes, 4 drugs (DrugBank), 42 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| [3] IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 17 | Antigen processing and presentation 1 gene, 3 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 18 | Apelin signaling pathway 4 genes, 7 drugs (DrugBank), 37 diseases shown |
[2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 19 | Apoptosis 4 genes, 7 drugs (DrugBank), 20 diseases shown |
[2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 20 | Arachidonic acid metabolism 2 genes, 4 drugs (DrugBank), 20 diseases shown |
[2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 21 | Asthma 2 genes, 3 drugs (DrugBank), 19 diseases shown |
[2] IL10, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 22 | Autoimmune thyroid disease 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] IL10 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 23 | Autophagy - animal 4 genes, 7 drugs (DrugBank), 37 diseases shown |
[2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 24 | Autophagy - other 1 gene, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 25 | Axon guidance 3 genes, 4 drugs (DrugBank), 13 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] MET |
D10062 |
Cabozantinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 26 | B cell receptor signaling pathway 3 genes, 4 drugs (DrugBank), 2 diseases shown |
[2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 27 | Bacterial invasion of epithelial cells 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] MET |
D10062 |
Cabozantinib |
[1] 34 |
| 28 | beta-Alanine metabolism 3 genes, 1 drug (DrugBank), 14 diseases shown |
[3] ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 29 | Bile secretion 1 gene, 2 drugs (DrugBank), 23 diseases shown |
[1] HMGCR |
D00359 |
Lovastatin |
[10] 6, 34, 46, 79, 156, 160, 195, 206, 263, 310 |
| D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 30 | Bladder cancer 7 genes, 10 drugs (DrugBank), 14 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 31 | Breast cancer 9 genes, 17 drugs (DrugBank), 44 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [4] BRAF, FLT4, KIT, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] FLT4 |
D03218 |
Axitinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| [2] FLT4, KIT |
D10062 |
Cabozantinib |
[1] 34 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 32 | Butanoate metabolism 4 genes, 1 drug (DrugBank), 14 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 33 | C-type lectin receptor signaling pathway 6 genes, 8 drugs (DrugBank), 34 diseases shown |
[4] IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 34 | Calcium signaling pathway 7 genes, 8 drugs (DrugBank), 26 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] PDGFRB |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 35 | cAMP signaling pathway 4 genes, 5 drugs (DrugBank), 2 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 36 | Cell cycle 1 gene, 2 drugs (DrugBank), 13 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 37 | Cellular senescence 6 genes, 9 drugs (DrugBank), 43 diseases shown |
[2] IL1A, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 38 | Central carbon metabolism in cancer 12 genes, 14 drugs (DrugBank), 44 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [4] FLT3, KIT, MET, RET |
D10062 |
Cabozantinib |
[1] 34 |
| [5] FLT3, KIT, PDGFRA, PDGFRB, RET |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [5] FLT3, KIT, PDGFRB, RAF1, RET |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 39 | cGMP-PKG signaling pathway 6 genes, 5 drugs (DrugBank), 12 diseases shown |
[3] ADRA2A, ADRA2B, ADRA2C |
D00514 |
Dexmedetomidine |
[11] 2, 4, 6, 21, 34, 70, 113, 212, 215, 226, 280 |
| D01205 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 40 | Chagas disease (American trypanosomiasis) 5 genes, 3 drugs (DrugBank), 19 diseases shown |
[5] CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 41 | Chemical carcinogenesis 1 gene, 4 drugs (DrugBank), 20 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| 42 | Chemokine signaling pathway 4 genes, 6 drugs (DrugBank), 11 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] CCL2 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] MAP2K1 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 43 | Choline metabolism in cancer 7 genes, 13 drugs (DrugBank), 44 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 44 | Cholinergic synapse 1 gene, 3 drugs (DrugBank), 1 disease shown |
[1] MAP2K1 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 45 | Chronic myeloid leukemia 5 genes, 7 drugs (DrugBank), 13 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 46 | Circadian entrainment 3 genes, 1 drug (DrugBank), 14 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 47 | Cocaine addiction 1 gene, 1 drug (DrugBank), 7 diseases shown |
[1] SLC6A3 |
D01296 |
Methylphenidate |
[7] 6, 13, 34, 84, 113, 179, 206 |
| D04999 |
| 48 | Colorectal cancer 6 genes, 11 drugs (DrugBank), 39 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 49 | Cortisol synthesis and secretion 3 genes, 1 drug (DrugBank), 14 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 50 | Cushing syndrome 7 genes, 9 drugs (DrugBank), 18 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 51 | Cytokine-cytokine receptor interaction 10 genes, 6 drugs (DrugBank), 35 diseases shown |
[6] CCL2, IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] CSF1 |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] CSF3R |
D03235 |
Filgrastim |
[28] 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| [2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 52 | Cytosolic DNA-sensing pathway 2 genes, 2 drugs (DrugBank), 13 diseases shown |
[2] IL1B, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 53 | Dilated cardiomyopathy (DCM) 1 gene, 3 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 54 | Dopaminergic synapse 2 genes, 2 drugs (DrugBank), 8 diseases shown |
[1] SCN1A |
D00354 |
Lamotrigine |
[3] 13, 34, 114 |
| [1] SLC6A3 |
D01296 |
Methylphenidate |
[7] 6, 13, 34, 84, 113, 179, 206 |
| D04999 |
| 55 | EGFR tyrosine kinase inhibitor resistance 14 genes, 21 drugs (DrugBank), 51 diseases shown |
[3] AXL, KDR, MET |
D10062 |
Cabozantinib |
[1] 34 |
| [1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [4] BRAF, KDR, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] KDR |
D03218 |
Axitinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| [3] KDR, PDGFRA, PDGFRB |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 56 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] VDR |
D00188 |
Cholecalciferol |
[15] 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| 57 | Endocrine resistance 7 genes, 11 drugs (DrugBank), 39 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 58 | Endocytosis 2 genes, 6 drugs (DrugBank), 16 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| 59 | Endometrial cancer 6 genes, 8 drugs (DrugBank), 7 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection 2 genes, 4 drugs (DrugBank), 7 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] MET |
D10062 |
Cabozantinib |
[1] 34 |
| 61 | Epstein-Barr virus infection 4 genes, 4 drugs (DrugBank), 20 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 62 | ErbB signaling pathway 8 genes, 13 drugs (DrugBank), 44 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 63 | Estrogen signaling pathway 4 genes, 7 drugs (DrugBank), 7 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 64 | Fc epsilon RI signaling pathway 4 genes, 7 drugs (DrugBank), 20 diseases shown |
[2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 65 | Fc gamma R-mediated phagocytosis 2 genes, 4 drugs (DrugBank), 2 diseases shown |
[1] MAP2K1 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 66 | Fluid shear stress and atherosclerosis 6 genes, 10 drugs (DrugBank), 26 diseases shown |
[4] CCL2, IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] KDR |
D03218 |
Axitinib |
[1] 34 |
| D10062 |
Cabozantinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 67 | Focal adhesion 12 genes, 16 drugs (DrugBank), 20 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [5] BRAF, FLT4, KDR, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [3] FLT1, FLT4, KDR |
D03218 |
Axitinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| [4] FLT1, FLT4, KDR, MET |
D10062 |
Cabozantinib |
[1] 34 |
| [5] FLT1, FLT4, KDR, PDGFRA, PDGFRB |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] MAP2K1 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 68 | Folate biosynthesis 2 genes, 1 drug (DrugBank), 33 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 69 | FoxO signaling pathway 7 genes, 10 drugs (DrugBank), 17 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] IL10, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 70 | GABAergic synapse 19 genes, 2 drugs (DrugBank), 21 diseases shown |
[3] ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| 71 | Gap junction 15 genes, 12 drugs (DrugBank), 18 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D01068 |
Vinblastine |
[1] 34 |
| D08675 |
| D02197 |
Vincristine |
[4] 26, 34, 61, 331 |
| D08679 |
| 72 | Gastric cancer 8 genes, 12 drugs (DrugBank), 39 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MET |
D10062 |
Cabozantinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 73 | Glioma 8 genes, 14 drugs (DrugBank), 44 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [3] BRAF, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| 74 | GnRH secretion 6 genes, 5 drugs (DrugBank), 15 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 75 | GnRH signaling pathway 4 genes, 7 drugs (DrugBank), 7 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 76 | Graft-versus-host disease 4 genes, 3 drugs (DrugBank), 19 diseases shown |
[4] IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 77 | Growth hormone synthesis, secretion and action 4 genes, 7 drugs (DrugBank), 37 diseases shown |
[2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 78 | Hematopoietic cell lineage 8 genes, 9 drugs (DrugBank), 40 diseases shown |
[3] CSF1, FLT3, KIT |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] CSF3R |
D03235 |
Filgrastim |
[28] 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| [2] FLT3, KIT |
D10062 |
Cabozantinib |
[1] 34 |
| D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [4] IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 79 | Hepatitis B 7 genes, 9 drugs (DrugBank), 21 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] IFNAR1 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 80 | Hepatitis C 8 genes, 12 drugs (DrugBank), 24 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 81 | Hepatocellular carcinoma 7 genes, 12 drugs (DrugBank), 39 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MET |
D10062 |
Cabozantinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 82 | Herpes simplex virus 1 infection 7 genes, 7 drugs (DrugBank), 48 diseases shown |
[4] CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 83 | HIF-1 signaling pathway 9 genes, 17 drugs (DrugBank), 48 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] FLT1 |
D03218 |
Axitinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [2] FLT1, TEK |
D10062 |
Cabozantinib |
[1] 34 |
| [1] IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 84 | Human cytomegalovirus infection 12 genes, 22 drugs (DrugBank), 62 diseases shown |
[4] CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 85 | Human immunodeficiency virus 1 infection 5 genes, 10 drugs (DrugBank), 47 diseases shown |
[2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 86 | Human papillomavirus infection 11 genes, 22 drugs (DrugBank), 62 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 87 | Human T-cell leukemia virus 1 infection 4 genes, 6 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 88 | Hypertrophic cardiomyopathy (HCM) 2 genes, 3 drugs (DrugBank), 19 diseases shown |
[2] IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 89 | IL-17 signaling pathway 5 genes, 7 drugs (DrugBank), 34 diseases shown |
[4] CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 90 | Inflammatory bowel disease (IBD) 5 genes, 3 drugs (DrugBank), 19 diseases shown |
[5] IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 91 | Inflammatory mediator regulation of TRP channels 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] IL1B |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 92 | Influenza A 11 genes, 9 drugs (DrugBank), 21 diseases shown |
[5] CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] TLR7 |
D02500 |
Imiquimod |
[1] 34 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 93 | Insulin resistance 3 genes, 6 drugs (DrugBank), 47 diseases shown |
[2] IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 94 | Insulin signaling pathway 5 genes, 8 drugs (DrugBank), 37 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 95 | Intestinal immune network for IgA production 2 genes, 2 drugs (DrugBank), 13 diseases shown |
[2] IL10, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 96 | JAK-STAT signaling pathway 10 genes, 14 drugs (DrugBank), 58 diseases shown |
[1] CSF3R |
D03235 |
Filgrastim |
[28] 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL10, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 97 | Kaposi sarcoma-associated herpesvirus infection 9 genes, 16 drugs (DrugBank), 55 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [1] IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 98 | Legionellosis 3 genes, 3 drugs (DrugBank), 19 diseases shown |
[3] IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 99 | Leishmaniasis 5 genes, 7 drugs (DrugBank), 34 diseases shown |
[4] IL10, IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 100 | Long-term depression 4 genes, 5 drugs (DrugBank), 2 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 101 | Long-term potentiation 4 genes, 5 drugs (DrugBank), 2 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 102 | Longevity regulating pathway 1 gene, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 103 | Longevity regulating pathway - multiple species 1 gene, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 104 | Malaria 6 genes, 4 drugs (DrugBank), 19 diseases shown |
[5] CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] MET |
D10062 |
Cabozantinib |
[1] 34 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 105 | MAPK signaling pathway 24 genes, 20 drugs (DrugBank), 40 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [7] BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [8] CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [8] FLT1, FLT3, FLT4, KDR, KIT, MET, NTRK2, TEK |
D10062 |
Cabozantinib |
[1] 34 |
| [3] FLT1, FLT4, KDR |
D03218 |
Axitinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| [3] IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 106 | Measles 6 genes, 4 drugs (DrugBank), 14 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [3] IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TLR7 |
D02500 |
Imiquimod |
[1] 34 |
| 107 | Melanogenesis 4 genes, 8 drugs (DrugBank), 13 diseases shown |
[1] KIT |
D10062 |
Cabozantinib |
[1] 34 |
| D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [2] KIT, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 108 | Melanoma 8 genes, 12 drugs (DrugBank), 16 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [3] BRAF, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MET |
D10062 |
Cabozantinib |
[1] 34 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| 109 | Metabolic pathways 9 genes, 8 drugs (DrugBank), 64 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| [1] HMGCR |
D00359 |
Lovastatin |
[10] 6, 34, 46, 79, 156, 160, 195, 206, 263, 310 |
| D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| [2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 110 | MicroRNAs in cancer 12 genes, 20 drugs (DrugBank), 54 diseases shown |
[2] ABL1, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [3] ABL1, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MET |
D10062 |
Cabozantinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [2] PDGFRA, PDGFRB |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 111 | Mineral absorption 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] VDR |
D00188 |
Cholecalciferol |
[15] 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| 112 | Morphine addiction 16 genes, 1 drug (DrugBank), 8 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| 113 | mTOR signaling pathway 6 genes, 11 drugs (DrugBank), 47 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 114 | Natural killer cell mediated cytotoxicity 7 genes, 9 drugs (DrugBank), 21 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 115 | Necroptosis 5 genes, 4 drugs (DrugBank), 20 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [3] IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 116 | Neuroactive ligand-receptor interaction 19 genes, 2 drugs (DrugBank), 16 diseases shown |
[3] ADRA2A, ADRA2B, ADRA2C |
D00514 |
Dexmedetomidine |
[11] 2, 4, 6, 21, 34, 70, 113, 212, 215, 226, 280 |
| D01205 |
| [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| 117 | Neurotrophin signaling pathway 6 genes, 8 drugs (DrugBank), 13 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] NTRK2 |
D10062 |
Cabozantinib |
[1] 34 |
| 118 | NF-kappa B signaling pathway 3 genes, 7 drugs (DrugBank), 34 diseases shown |
[2] IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 119 | Nicotine addiction 16 genes, 1 drug (DrugBank), 8 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| 120 | NOD-like receptor signaling pathway 6 genes, 4 drugs (DrugBank), 20 diseases shown |
[4] CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 121 | Non-alcoholic fatty liver disease (NAFLD) 4 genes, 3 drugs (DrugBank), 19 diseases shown |
[4] IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 122 | Non-small cell lung cancer 6 genes, 8 drugs (DrugBank), 7 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 123 | One carbon pool by folate 2 genes, 1 drug (DrugBank), 33 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 124 | Oocyte meiosis 1 gene, 3 drugs (DrugBank), 1 disease shown |
[1] MAP2K1 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 125 | Osteoclast differentiation 7 genes, 8 drugs (DrugBank), 20 diseases shown |
[1] CSF1 |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [3] IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] MAP2K1 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 126 | Ovarian steroidogenesis 1 gene, 4 drugs (DrugBank), 20 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| 127 | Oxytocin signaling pathway 5 genes, 11 drugs (DrugBank), 23 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 128 | Pancreatic cancer 7 genes, 13 drugs (DrugBank), 43 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] MAP2K1 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 129 | Parathyroid hormone synthesis, secretion and action 5 genes, 9 drugs (DrugBank), 21 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] MAP2K1 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] VDR |
D00188 |
Cholecalciferol |
[15] 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| 130 | Parkinson disease 1 gene, 1 drug (DrugBank), 7 diseases shown |
[1] SLC6A3 |
D01296 |
Methylphenidate |
[7] 6, 13, 34, 84, 113, 179, 206 |
| D04999 |
| 131 | Pathogenic Escherichia coli infection 13 genes, 7 drugs (DrugBank), 28 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [3] IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D01068 |
Vinblastine |
[1] 34 |
| D08675 |
| D02197 |
Vincristine |
[4] 26, 34, 61, 331 |
| D08679 |
| 132 | Pathways in cancer 21 genes, 27 drugs (DrugBank), 66 diseases shown |
[3] ABL1, KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [4] ABL1, KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [7] BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] CSF3R |
D03235 |
Filgrastim |
[28] 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [5] FLT3, FLT4, KIT, MET, RET |
D10062 |
Cabozantinib |
[1] 34 |
| [6] FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] FLT4 |
D03218 |
Axitinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| [2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [1] IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 133 | PD-L1 expression and PD-1 checkpoint pathway in cancer 5 genes, 10 drugs (DrugBank), 39 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 134 | Pertussis 5 genes, 3 drugs (DrugBank), 19 diseases shown |
[5] IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 135 | Phagosome 9 genes, 2 drugs (DrugBank), 4 diseases shown |
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D01068 |
Vinblastine |
[1] 34 |
| D08675 |
| D02197 |
Vincristine |
[4] 26, 34, 61, 331 |
| D08679 |
| 136 | Phospholipase D signaling pathway 8 genes, 14 drugs (DrugBank), 44 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] KIT |
D10062 |
Cabozantinib |
[1] 34 |
| [2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [3] KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 137 | PI3K-Akt signaling pathway 22 genes, 22 drugs (DrugBank), 60 diseases shown |
[8] CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] CSF3R |
D03235 |
Filgrastim |
[28] 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [8] FLT1, FLT3, FLT4, KDR, KIT, MET, NTRK2, TEK |
D10062 |
Cabozantinib |
[1] 34 |
| [3] FLT1, FLT4, KDR |
D03218 |
Axitinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| [6] FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [1] IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 138 | Platelet activation 1 gene, 3 drugs (DrugBank), 16 diseases shown |
[1] PTGS1 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| 139 | Platinum drug resistance 3 genes, 3 drugs (DrugBank), 15 diseases shown |
[1] ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] TOP2A, TOP2B |
D03899 |
Doxorubicin |
[6] 26, 28, 34, 61, 63, 331 |
| D00125 |
Etoposide |
[11] 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 |
| D04107 |
| 140 | Prion diseases 5 genes, 5 drugs (DrugBank), 13 diseases shown |
[3] IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 141 | Progesterone-mediated oocyte maturation 3 genes, 5 drugs (DrugBank), 2 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] MAP2K1 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 142 | Prolactin signaling pathway 3 genes, 4 drugs (DrugBank), 2 diseases shown |
[2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 143 | Propanoate metabolism 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] ABAT |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 144 | Prostate cancer 9 genes, 14 drugs (DrugBank), 44 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [3] BRAF, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| 145 | Proteoglycans in cancer 11 genes, 20 drugs (DrugBank), 52 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [3] BRAF, KDR, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] KDR |
D03218 |
Axitinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [2] KDR, MET |
D10062 |
Cabozantinib |
[1] 34 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 146 | Rap1 signaling pathway 15 genes, 16 drugs (DrugBank), 20 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [6] BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [7] CSF1, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [3] FLT1, FLT4, KDR |
D03218 |
Axitinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| [6] FLT1, FLT4, KDR, KIT, MET, TEK |
D10062 |
Cabozantinib |
[1] 34 |
| [2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 147 | Ras signaling pathway 17 genes, 15 drugs (DrugBank), 20 diseases shown |
[3] ABL1, KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [4] ABL1, KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [8] CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [8] FLT1, FLT3, FLT4, KDR, KIT, MET, NTRK2, TEK |
D10062 |
Cabozantinib |
[1] 34 |
| [3] FLT1, FLT4, KDR |
D03218 |
Axitinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| [6] FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 148 | Regulation of actin cytoskeleton 7 genes, 11 drugs (DrugBank), 16 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [3] BRAF, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| 149 | Regulation of lipolysis in adipocytes 2 genes, 4 drugs (DrugBank), 20 diseases shown |
[2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 150 | Relaxin signaling pathway 5 genes, 9 drugs (DrugBank), 14 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 151 | Renal cell carcinoma 6 genes, 8 drugs (DrugBank), 11 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MET |
D10062 |
Cabozantinib |
[1] 34 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 152 | Retrograde endocannabinoid signaling 17 genes, 5 drugs (DrugBank), 24 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| 153 | Rheumatoid arthritis 9 genes, 9 drugs (DrugBank), 26 diseases shown |
[5] CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] CSF1, FLT1 |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [1] FLT1 |
D03218 |
Axitinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| [2] FLT1, TEK |
D10062 |
Cabozantinib |
[1] 34 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 154 | RIG-I-like receptor signaling pathway 1 gene, 3 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 155 | Salmonella infection 3 genes, 2 drugs (DrugBank), 13 diseases shown |
[3] IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 156 | Serotonergic synapse 8 genes, 10 drugs (DrugBank), 24 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [3] GABRB1, GABRB2, GABRB3 |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| [1] MAP2K1 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] PTGS2 |
D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 157 | Shigellosis 5 genes, 11 drugs (DrugBank), 53 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| D11251 |
Icotinib |
[1] 34 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 158 | Signaling pathways regulating pluripotency of stem cells 3 genes, 4 drugs (DrugBank), 2 diseases shown |
[2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 159 | Small cell lung cancer 1 gene, 4 drugs (DrugBank), 20 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| 160 | Sphingolipid signaling pathway 4 genes, 7 drugs (DrugBank), 20 diseases shown |
[2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 161 | Staphylococcus aureus infection 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] IL10 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 162 | Synaptic vesicle cycle 2 genes, 1 drug (DrugBank), 7 diseases shown |
[2] SLC6A2, SLC6A3 |
D01296 |
Methylphenidate |
[7] 6, 13, 34, 84, 113, 179, 206 |
| D04999 |
| 163 | Systemic lupus erythematosus 2 genes, 3 drugs (DrugBank), 19 diseases shown |
[2] IL10, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 164 | T cell receptor signaling pathway 5 genes, 7 drugs (DrugBank), 20 diseases shown |
[2] IL10, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 165 | Taste transduction 9 genes, 2 drugs (DrugBank), 10 diseases shown |
[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| [3] SCN2A, SCN3A, SCN9A |
D00354 |
Lamotrigine |
[3] 13, 34, 114 |
| 166 | Taurine and hypotaurine metabolism 2 genes, 1 drug (DrugBank), 14 diseases shown |
[2] GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 167 | Terpenoid backbone biosynthesis 3 genes, 3 drugs (DrugBank), 23 diseases shown |
[2] FNTA, FNTB |
D03720 |
Tipifarnib |
[1] 34 |
| [1] HMGCR |
D00359 |
Lovastatin |
[10] 6, 34, 46, 79, 156, 160, 195, 206, 263, 310 |
| D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 168 | TGF-beta signaling pathway 1 gene, 3 drugs (DrugBank), 19 diseases shown |
[1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 169 | Th17 cell differentiation 3 genes, 5 drugs (DrugBank), 43 diseases shown |
[2] IL1B, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] IL6 |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 170 | Thermogenesis 1 gene, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| 171 | Thyroid cancer 4 genes, 7 drugs (DrugBank), 3 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RET |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] RET |
D10062 |
Cabozantinib |
[1] 34 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| 172 | Thyroid hormone signaling pathway 4 genes, 7 drugs (DrugBank), 37 diseases shown |
[2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 173 | Tight junction 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 174 | TNF signaling pathway 7 genes, 11 drugs (DrugBank), 34 diseases shown |
[4] CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] CSF1 |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] MAP2K1 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 175 | Toll-like receptor signaling pathway 8 genes, 8 drugs (DrugBank), 20 diseases shown |
[2] IFNAR1, IFNAR2 |
D02745 |
Interferon alfa-2b |
[3] 25, 34, 227 |
| [3] IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] TLR7 |
D02500 |
Imiquimod |
[1] 34 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 176 | Toxoplasmosis 2 genes, 3 drugs (DrugBank), 19 diseases shown |
[2] IL10, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 177 | Transcriptional misregulation in cancer 4 genes, 7 drugs (DrugBank), 14 diseases shown |
[1] FLT1 |
D03218 |
Axitinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| [2] FLT1, FLT3 |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [3] FLT1, FLT3, MET |
D10062 |
Cabozantinib |
[1] 34 |
| [1] FLT3 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 178 | Tuberculosis 7 genes, 5 drugs (DrugBank), 30 diseases shown |
[5] IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| [1] VDR |
D00188 |
Cholecalciferol |
[15] 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| 179 | Type I diabetes mellitus 5 genes, 4 drugs (DrugBank), 29 diseases shown |
[2] GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [3] IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 180 | Type II diabetes mellitus 3 genes, 7 drugs (DrugBank), 53 diseases shown |
[1] CACNA1G |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| D06068 |
Temsirolimus |
[4] 13, 34, 89, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| 181 | Valine, leucine and isoleucine degradation 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] ABAT |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 182 | Vascular smooth muscle contraction 4 genes, 5 drugs (DrugBank), 2 diseases shown |
[1] BRAF |
D10064 |
Dabrafenib |
[1] 34 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| 183 | VEGF signaling pathway 6 genes, 14 drugs (DrugBank), 28 diseases shown |
[1] KDR |
D03218 |
Axitinib |
[1] 34 |
| D10062 |
Cabozantinib |
[1] 34 |
| D08881 |
Cediranib |
[1] 34 |
| D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [2] KDR, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
[9] 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
[4] 13, 34, 46, 271 |
| D00904 |
| D07816 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| D05697 |
Ranibizumab |
[4] 34, 166, 227, 301 |
| 184 | Viral myocarditis 1 gene, 2 drugs (DrugBank), 13 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 185 | Viral protein interaction with cytokine and cytokine receptor 5 genes, 4 drugs (DrugBank), 19 diseases shown |
[4] CCL2, IL10, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] CSF1 |
D06402 |
Sunitinib |
[2] 28, 34 |
| D08552 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |
| 186 | Yersinia infection 7 genes, 6 drugs (DrugBank), 19 diseases shown |
[5] CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [2] IL6, TNF |
D08976 |
Pomalidomide |
[6] 28, 34, 51, 85, 227, 331 |
| [2] MAP2K1, MAP2K2 |
D10604 |
Binimetinib |
[1] 34 |
| D09666 |
Selumetinib |
[1] 34 |
| D10175 |
Trametinib |
[1] 34 |
| [1] TNF |
D04687 |
Lenalidomide |
[8] 16, 26, 28, 34, 49, 96, 284, 300 |